A method of treating hemodynamic disfunction by simultaneously pacing both ventricles of a heart. At least one ECG amplifier is arranged to separately detect contraction of each ventricle and a stimulator is then activated for issuing stimulating pulses to both ventricles in a manner to assure simultaneous contraction of both ventricles, thereby to assure hemodynamic efficiency. A first ventricle is stimulated simultaneously with contraction of a second ventricle when the first fails to properly contract. Further, both ventricles are stimulated after lapse of a predetermined A-V escape interval. One of a pair of electrodes, connected in series, in placed through the superior vena cava into the right ventricle and a second is placed in the coronary sinus about the left ventricle. Each electrode performs both pacing and sensing functions. The pacer is particularly suitable for treating bundle branch blocks or slow conduction in a portion of the ventricles.
|
0. 102. A heart stimulating device for treating heart failure, comprising:
an electrode to sense ventricular depolarization signals originating from the right ventricle; and
a pulse generator operative upon sensing of a ventricular depolarization signal to apply a stimulating pulse to another ventricle.
0. 96. A method for improving the hemodynamic efficiency of a heart, comprising:
sensing ventricular depolarization signals originating from the right ventricle; and
applying a stimulating pulse to another ventricle in response to the sensing of a ventricular depolarization signal originating from the right ventricle.
0. 73. A method for improving the hemodynamic efficiency of a heart, comprising:
sensing a cardiac depolarization signal from a first ventricle;
receiving the ventricular cardiac depolarization signal; and
issuing a stimulating pulse to a second ventricle in response to the ventricular cardiac depolarization signal.
0. 114. A method for improving the hemodynamic efficiency of a heart, comprising:
sensing ventricular depolarization signals originating from the left ventricle; and
applying a stimulating pulse to another ventricle in response to the sensing of the ventricular depolarization signals originating from the left ventricle.
0. 128. A method for improving the hemodynamic efficiency of a heart, comprising:
sensing for the presence of cardiac depolarization signals from a ventricle; and
stimulating both ventricles in the event that no cardiac depolarization signals are sensed from either ventricle within a predetermined atrial-ventricular delay period.
0. 108. A heart stimulating device for treating heart failure, comprising:
means for sensing ventricular depolarization signals originating from the left ventricle; and
means for applying a stimulating pulse to another ventricle in response to the sensing means sensing ventricular depolarization signals originating from the left ventricle.
0. 90. A heart stimulating device for treating heart failure, comprising:
means for sensing ventricular depolarization signals originating from the right ventricle; and
means for applying a stimulating pulse to another ventricle in response to the sensing means sensing a ventricular depolarization signal originating from the right ventricle.
0. 155. A method for improving the hemodynamic efficiency of a heart, comprising:
detecting a cardiac depolarization signal originating from a first ventricle; and
unconditionally stimulating both ventricles for effecting a coordinated contraction of both ventricles when a cardiac depolarization signal originating from the first ventricle is detected.
0. 84. A heart stimulating device for treating heart failure, comprising:
an electrode to sense ventricular depolarization signals originating from the right ventricle; and
a pulse generator, connected to the electrode, operative upon sensing of a ventricular depolarization signal from the right ventricle to apply a stimulating pulse to another ventricle.
0. 39. A method for improving the hemodynamic efficiency of a heart, comprising:
receiving ventricular depolarization signals originating from a first ventricle;
generating a stimulating pulse in response to the receiving of a ventricular depolarization signal; and
applying the stimulating pulse to a second ventricle in response to the receiving of a ventricular depolarization signal.
0. 62. A heart stimulating device for treating heart failure comprising:
means for sensing a cardiac depolarization signal from a first ventricle;
means, connected to the sensing means, for receiving the cardiac depolarization signal; and
means, connected to the receiving means, for issuing a stimulating pulse to a second ventricle in response to the ventricular cardiac depolarization signal.
0. 51. A heart stimulating device for treating heart failure comprising:
an electrode to sense a cardiac depolarization signal from a first ventricle;
a sense amplifier, connected to the electrode, to process the cardiac depolarization signal; and
a stimulator, connected to the sense amplifier, to issue a stimulating pulse to a second ventricle in response to the ventricular cardiac depolarization signal.
0. 146. A method for treating congestive heart failure, comprising:
receiving ventricular depolarization signals originating from the right ventricle;
generating a stimulating pulse in response to the receiving of a ventricular depolarization signal in the right ventricle; and
applying the stimulating pulse to the left ventricle in response to the receiving of a ventricular depolarization signal in the right ventricle.
0. 27. A heart stimulating device for treating heart failure, comprising:
means for receiving ventricular depolarization signals originating from a first ventricle;
means for generating a stimulating pulse in the event the receiving means receives a ventricular depolarization signal; and
means for applying the stimulating pulse to a second ventricle in the event the receiving means receives a ventricular depolarization signal.
0. 152. A method for treating a heart suffering from heart failure, comprising:
receiving ventricular depolarization signals originating from the left ventricle;
generating a stimulating pulse in response to the receiving of a ventricular depolarization signal in the left ventricle; and
applying the stimulating pulse to the right ventricle in response to the receiving of a ventricular depolarization signal in the left ventricle.
0. 310. A method of improving the pumping ability of a heart suffering from heart failure comprising:
sensing for depolarization signals originating from a first ventricle; and
stimulating a second ventricle when a depolarization signal from the first ventricle is detected for effecting a coordinate contraction of ventricles contracting in an incoordinate manner to improve the pumping ability of the heart suffering from heart failure.
0. 124. A heart stimulating device for treating heart failure, comprising:
means for sensing atrial cardiac depolarization signals originating from an atrial chamber;
means for sensing ventricular cardiac depolarization signals originating from a ventricular chamber;
means for applying stimulating pulses to both ventricles in the event that no ventricular cardiac depolarization signals are sensed within a predetermined atrial-ventricular delay period.
0. 171. A method of improving the pumping ability of a heart suffering from heart failure comprising:
sensing for depolarization signals only from one ventricle of the heart;
stimulating the left ventricle and the right ventricle when a depolarization signal from the one ventricle is detected for effecting a coordinate contraction of ventricles contracting in an incoordinate manner to improve the pumping ability of the heart suffering from heart failure.
0. 136. A method for treating congestive heart failure comprising:
locating a sensing electrode in an atrium;
locating a pacing electrode through the coronary sinus in the left ventricle;
locating a sensing electrode in the right ventricle;
sensing for cardiac signals from the sensing electrode in the right ventricle;
detecting the cardiac signals; and
effecting simultaneous contraction of both ventricles after a predetermined A-V delay period.
0. 315. A method of improving the pumping ability of a heart suffering from heart failure comprising:
sensing for depolarization signals originating from only one ventricle; and
stimulating a right ventricle and a left ventricle if a depolarization signal is not detected from the one ventricle during a time period for effecting a coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability of a heart suffering from heart failure.
0. 120. A heart stimulating device for treating heart failure, comprising:
a first electrode to sense atrial cardiac depolarization signals originating from an atrial chamber;
a second electrode to sense ventricular cardiac depolarization signals originating from a ventricular chamber;
a pulse generator operative to apply stimulating pulses to both ventricles in the event that no ventricular cardiac depolarization signals are sensed within a predetermined atrial-ventricular delay period.
0. 132. An atrial-coupled bi-ventricular stimulating device for treatment of congestive heart failure comprising:
atrial and ventricular sensing means for detecting cardiac signals originating in an atrium and in a ventricle;
a control circuit connected to said sensing means to receive the cardiac signals and provide a control signal; and
a stimulating circuit for effecting simultaneous contraction of both ventricles in response to the control signal of the control circuit after a predetermined A-V delay period.
0. 15. A heart stimulating device for treating heart failure, comprising:
a sense amplifier to receive ventricular depolarization signals originating from a first ventricle;
a pulse generator, connected to the sense amplifier, to generate a stimulating pulse in the event the sense amplifier receives a ventricular depolarization signal; and
an electrode, connected to the pulse generator, to apply the stimulating pulse to a second ventricle in the event the sense amplifier receives a ventricular depolarization signal.
0. 158. A heart stimulating device for treating heart failure, comprising:
an electrode adapted to be disposed in or about a first ventricle for detecting a cardiac depolarization signal originating from the first ventricle;
a sense amplifier to receive the cardiac depolarization signal originating from the first ventricle;
a pulse generator, connected to the sense amplifier, to unconditionally stimulate both ventricles for effecting a coordinated contraction of both ventricles when the cardiac depolarization signal from the first ventricle is detected.
0. 161. A method of improving the pumping ability of a heart suffering from heart failure comprising:
sensing for depolarization signals originating from a left ventricle;
sensing for depolarization signals originating from a right ventricle; and
stimulating the left ventricle and the right ventricle when a depolarization signal from either the left ventricle or the right ventricle is detected for effecting a coordinate contraction of ventricles contracting in an incoordinate manner to improve the pumping ability of the heart suffering from heart failure.
0. 324. A method for improving the pumping ability of a heart suffering from heart failure comprising:
sensing for depolarization signals origination in an atrium;
sensing for depolarization signals originating from only one ventricle; and
stimulating the left ventricle and the right ventricle after a time period if a depolarization signal is not detected from the one ventricle during the time period for effecting a coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability of a heart suffering from heart failure.
0. 308. A method for improving the pumping ability of a heart suffering from heart failure comprising:
positioning a first electrode through the coronary sinus to the left ventricle;
positioning a second electrode in the right ventricle;
applying a pacing pulse to the left ventricle through the first electrode;
applying a pacing pulse to the right ventricle through the second electrode substantially simultaneously with application of the pacing pulse to the left ventricle, wherein the pacing pulses are applied to the left ventricle and the right ventricle at a programmed rate.
0. 140. A method of effecting simultaneous contraction of both left and right ventricles of a heart for improving hemodynamic efficiency comprising:
locating a pacing electrode through the coronary sinus to the left ventricle;
sensing the cardiac signals of the atria and separately sensing the cardiac depolarization signals of the right ventricle;
detecting the cardiac signals of the atria and the cardiac depolarization signals of the right ventricle; and
stimulating the left ventricle simultaneously with the contraction of the right ventricle after a predetermined A-V delay period.
0. 314. A method of improving the pumping ability of a heart suffering from heart failure comprising:
sensing for depolarization signals originating from a left ventricle;
sensing for depolarization signals originating from a right ventricle; and
stimulating the left ventricle and the right ventricle after a time period if a depolarization signal is not detected from either the left ventricle or the right ventricle during the time period for effecting a coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability of a heart suffering from heart failure.
0. 316. A method for improving the pumping ability of a heart suffering from heart failure comprising:
sensing for depolarization signals origination in an atrium;
sensing for depolarization signals originating from a left ventricle;
sensing for depolarization signals originating from a right ventricle; and
stimulating the left ventricle and the right ventricle after a time period if a depolarization signal is not detected from either the left ventricle or the right ventricle during the time period for effecting a coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability of a heart suffering from heart failure.
0. 216. A method for improving the pumping ability of a heart suffering from heart failure comprising:
sensing for depolarization signals originating from an atrium;
beginning an atrial-ventricular delay period upon sensing a depolarization signal of the atrium;
sensing for depolarization signals originating from only one ventricle; and
stimulating the left ventricle and the right ventricle at the end of the atrial-ventricular delay period if a depolarization signal is not detected from the one ventricle during the atrial-ventricular delay period for effecting a coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability to the heart suffering form heart failure.
0. 287. A method of improving the pumping ability of a heart suffering from heart failure comprising:
sensing for depolarization signals originating from an atrium;
beginning an atrial-ventricular delay period upon sensing a depolarization signal of the atrium;
sensing for depolarization signals originating from only one ventricle;
inhibiting stimulation of the left ventricle and the right ventricle when a depolarization signal from the one ventricle is detected during the atrial-ventricular delay period; and
stimulating the left ventricle and the right ventricle at the end of the atrial-ventricular delay period if a depolarization signal is not detected from the one ventricle during the atrial-ventricular delay period.
0. 133. An atrial-coupled bi-ventricular stimulating device for implantation or external use for treating heart failure comprising:
a sensing electrode adapted to be located in an atrium;
a pacing electrode adapted to be located through the coronary sinus in the left ventricle;
a sensing electrode adapted to be located in the right ventricle;
ventricular sensing means for detecting cardiac signals from the sensing electrode adapted to be in the right ventricle;
a control circuit connected to said sensing means to provide a control signal in response to detecting a cardiac signal; and
a stimulating circuit for effecting simultaneous contraction of both ventricles in response to the control signal of the control circuit after a predetermined A-V delay period.
0. 149. A heart stimulating device for treating heart failure, comprising:
an electrode adapted to be disposed in or about the left ventricle to sense ventricular depolarization signals originating from the left ventricle;
a sense amplifier to receive the ventricular depolarization signals originating from the left ventricle;
a pulse generator, connected to the sense amplifier, to generate a stimulating pulse in the event the sense amplifier receives a ventricular depolarization signal originating from the left ventricle; and
an electrode, adapted to be disposed in or about the right ventricle and connected to the pulse generator, to apply the stimulating pulse to the right ventricle in the event the sense amplifier receives a ventricular depolarization signal originating from the left ventricle.
0. 143. A heart stimulating device for treating heart failure, comprising:
an electrode adapted to be disposed in or about the right ventricle to sense ventricular depolarization signals originating from the right ventricle;
a sense amplifier to receive the ventricular depolarization signals originating from the right ventricle;
a pulse generator, connected to the sense amplifier, to generate a stimulating pulse in the event the sense amplifier receives a ventricular depolarization signal originating from the right ventricle; and
an electrode, adapted to be disposed in or about the left ventricle and connected to the pulse generator, to apply the stimulating pulse to the left ventricle in the event the sense amplifier receives a ventricular depolarization signal originating from the right ventricle.
0. 210. A method for improving the pumping ability of a heart suffering from heart failure comprising:
sensing for depolarization signals originating from an atrium;
beginning an atrial-ventricular delay period upon sensing a depolarization signal of the atrium;
sensing for depolarization signals originating from a left ventricle;
sensing for depolarization signals originating from a right ventricle; and
stimulating the left ventricle and the right ventricle at the end of the atrial-ventricular delay period if a depolarization signal is not detected from either the left ventricle or the right ventricle during the atrial-ventricular delay period for effecting a coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability to the heart suffering form heart failure.
0. 281. A method of improving the pumping ability of a heart suffering from heart failure comprising:
sensing for depolarization signals originating from an atrium;
beginning an atrial-ventricular delay period upon sensing a depolarization signal of the atrium;
sensing for depolarization signals originating from a left ventricle;
sensing for depolarization signals originating from a right ventricle;
inhibiting stimulation of the left ventricle and the right ventricle when a depolarization signal from either the left ventricle or the right ventricle is detected during the atrial-ventricular delay period; and
stimulating the left ventricle and the right ventricle at the end of the atrial-ventricular delay period if a depolarization signal is not detected from either the left ventricle or the right ventricle during the atrial-ventricular delay period.
0. 232. A heart failure treatment device for improving the pumping ability of a heart suffering from heart failure comprising:
an atrial sense amplifier for detecting depolarization signals originating from an atrium;
a ventricular sense amplifier for detecting depolarization signals originating from only one ventricle;
pacing control circuitry, connected to the atrial sense amplifier, for starting an atrial-ventricular delay period when the atrial sense amplifier detects an atrial depolarization signal; and
a stimulating circuit capable of stimulating the left ventricle and the right ventricle at the end of the atrial-ventricular delay if a depolarization signal is not detected from the one ventricle during the atrial-ventricular delay period for effecting coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability to the heart suffering form heart failure.
0. 247. A method of improving the pumping ability of a heart suffering from heart failure comprising:
sensing for depolarization signals originating from an atrium;
beginning an atrial-ventricular delay period upon sensing a depolarization signal of the atrium;
sensing for depolarization signals originating from only one ventricle;
stimulating the left ventricle and the right ventricle when a depolarization signal from the one ventricle is detected during the atrial-ventricular delay period for effecting a coordinated contraction of the ventricles; and
stimulating the left ventricle and the right ventricle at the end of the atrial-ventricular delay period if a depolarization signal is not detected from the one ventricle during the atrial-ventricular delay period for effecting a coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability of the heart suffering from heart failure.
0. 224. A heart failure treatment device for improving the pumping ability of a heart suffering from heart failure comprising:
an atrial sense amplifier for detecting depolarization signals originating from an atrium;
a ventricular sense amplifier for detecting depolarization signals originating from a left ventricle and a right ventricle;
pacing control circuitry, connected to the atrial sense amplifier, for starting an atrial-ventricular delay period when the atrial sense amplifier detects an atrial depolarization signal; and
a stimulating circuit capable of stimulating the left ventricle and the right ventricle at the end of the atrial-ventricular delay period if a depolarization signal is not detected from either the left ventricle or the right ventricle during the atrial-ventricular delay period for effecting coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability to the heart suffering form heart failure.
0. 238. A method of improving the pumping ability of a heart suffering from heart failure comprising:
sensing for depolarization signals originating from an atrium;
beginning an atrial-ventricular delay period upon sensing a depolarization signal of the atrium;
sensing for depolarization signals originating from a left ventricle;
sensing for depolarization signals originating from a right ventricle; and
stimulating the left ventricle and the right ventricle when a depolarization signal from either the left ventricle or the right ventricle is detected during the atrial-ventricular delay period for effecting a coordinated contraction of the ventricles contracting in an incoordinate manner to improve the pumping ability of the heart suffering from heart failure; and
stimulating the left ventricle and the right ventricle at the end of the atrial-ventricular delay period if a depolarization signal is not detected from either the left ventricle or the right ventricle during the atrial-ventricular delay period for effecting a coordinated contraction of the ventricles.
0. 302. A heart failure treatment device for improving the pumping ability of a heart suffering from heart failure comprising:
an atrial sense amplifier for detecting depolarization signals originating from an atrium;
a ventricular sense amplifier for detecting depolarization signals originating from only one ventricle;
pacing control circuitry, connected to the atrial sense amplifier, for starting an atrial-ventricular delay period when the atrial sense amplifier detects an atrial depolarization signal, and for inhibiting stimulation of the left ventricle and the right ventricle when a depolarization signal from the one ventricle is detected during the atrial-ventricular delay period; and
a stimulating circuit for stimulating the left ventricle and the right ventricle at the end of the atrial-ventricular delay period if a depolarization signal is not detected from the one ventricle during the atrial-ventricular delay period for effecting a coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability of the heart suffering from heart failure.
0. 200. A heart failure treatment device for improving the pumping ability of a heart suffering from heart failure comprising:
a sense amplifier for receiving depolarization signals originating from only one ventricle of the heart;
a pulse generator, connected to the amplifier for generating stimulation pulses for application to the left ventricle and the right ventricle when the sense amplifier receives a ventricular depolarization signal originating from the one ventricle for effecting a coordinated contraction of the ventricles to improve the pumping ability of the heart suffering from heart failure;
a first electrode connected to the pulse generator and adapted to be disposed in or about the left ventricle for applying a stimulation pulse to the left ventricle when the sense amplifier receives a ventricular depolarization signal originating from the one ventricle; and
a second electrode connected to the pulse generator and adapted to be disposed in or about the right ventricle for applying a stimulation pulse to the right ventricle when the sense amplifier receives a ventricular depolarization signal originating from the one ventricle.
0. 293. A heart failure treatment device for improving the pumping ability of a heart suffering from heart failure comprising:
an atrial sense amplifier for detecting depolarization signals originating from an atrium;
a ventricular sense amplifier for detecting depolarization signals originating from a left ventricle and a right ventricle;
pacing control circuitry, connected to the atrial sense amplifier, for starting an atrial-ventricular delay period when the atrial sense amplifier detects an atrial depolarization signal, and for inhibiting stimulation of the left ventricle and the right ventricle when a depolarization signal from either the left or the right ventricle is detected during the atrial-ventricular delay period; and
a stimulating circuit for stimulating the left ventricle and the right ventricle at the end of the atrial-ventricular delay period if a depolarization signal is not detected from either the left ventricle or the right ventricle during the atrial-ventricular delay period for effecting a coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability of the heart suffering from heart failure.
0. 272. A heart failure treatment device for improving the pumping ability of a heart suffering from heart failure comprising:
an atrial sense amplifier for detecting depolarization signals originating from an atrium;
pacing control circuitry, connected to the atrial sense amplifier, for starting an atrial-ventricular delay period when the atrial sense amplifier detects an atrial depolarization signal;
a ventricular sense amplifier for detecting depolarization signals originating from only one ventricle; and
a stimulating circuit for stimulating the left ventricle and the right ventricle when a depolarization signal from the one ventricle is detected by the ventricular sense amplifier during the atrial-ventricular delay period for effecting a coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability of the heart suffering from heart failure; and for stimulating the left ventricle and the right ventricle at the end of the atrial-ventricular delay period if a depolarization signal is not detected from the one ventricle during the atrial-ventricular delay period for effecting a coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability of the heart suffering from heart failure.
0. 258. A heart failure treatment device for improving the pumping ability of a heart suffering from heart failure comprising:
an atrial sense amplifier for detecting depolarization signals originating from an atrium;
pacing control circuitry, connected to the atrial sense amplifier, for starting an atrial-ventricular delay period when the atrial sense amplifier detects an atrial depolarization signal;
a ventricular sense amplifier for detecting depolarization signals originating from a left ventricle and a right ventricle; and
a stimulating circuit for stimulating the left ventricle and the right ventricle when a depolarization signal from either the left or the right ventricle is detected by the ventricular sense amplifier during the atrial-ventricular delay period for effecting a coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability of the heart suffering from heart failure; and for stimulating the left ventricle and the right ventricle at the end of the atrial-ventricular delay period if a depolarization signal is not detected from either the left or right ventricles during the atrial-ventricular delay period for effecting a coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability of the heart suffering from heart failure.
0. 183. A heart failure treatment device for improving the pumping ability of a heart suffering from heart failure comprising:
a sense amplifier for receiving depolarization signals originating from left and right ventricles; and
a pulse generator, connected to the sense amplifier, that generates stimulation pulses for application to the left ventricle and the right ventricle when the sense amplifier receives a ventricular depolarization signal originating from either the left ventricle or the right ventricle for effecting a coordinated contraction of the ventricles to improve the pumping ability of the heart suffering from heart failure;
a first electrode connected to the pulse generator and adapted to be disposed in or about the left ventricle for sensing depolarization signals originating from the left ventricle and for applying a stimulation pulse to the left ventricle when the sense amplifier receives a ventricular depolarization signal originating from either the left ventricle or the right ventricle; and
a second electrode connected to the pulse generator and adapted to be disposed in or about the right ventricle for sensing depolarization signals originating from the right ventricle and for applying a stimulation pulse to the right ventricle when the sense amplifier receives a ventricular depolarization signal originating from either the left ventricle or the right ventricle.
0. 192. A heart failure treatment device for improving the pumping ability of a heart suffering from heart failure comprising:
a sense amplifier for receiving depolarization signals originating from a left ventricle or a right ventricle;
a pulse generator, connected to the sense amplifier, that generates stimulation pulses for application to the left ventricle and the right ventricle when the sense amplifier receives a ventricular depolarization signal originating from the left ventricle or the right ventricle for effecting a coordinated contraction of the ventricles to improve the pumping ability of the heart suffering from heart failure;
a first electrode connected to the pulse generator and adapted to be disposed in or about the left ventricle, the first electrode capable of sensing depolarization signals originating from the left ventricle and capable of applying a stimulation pulse to the left ventricle when the sense amplifier receives a ventricular depolarization signal originating from the left ventricle or the right ventricle; and
a second electrode connected to the pulse generator and adapted to be disposed in or about the right ventricle, the second electrode capable of sensing depolarization signals originating from the right ventricle and capable of applying a stimulation pulse to the right ventricle when the sense amplifier receives a ventricular depolarization signal originating from the left ventricle or the right ventricle.
0. 298. A heart failure treatment device for improving the pumping ability of a heart suffering from heart failure comprising:
an atrial sense amplifier for detecting depolarization signals originating from an atrium;
a ventricular sense amplifier for detecting depolarization signals originating from a left ventricle or a right ventricle;
pacing control circuitry, connected to the atrial sense amplifier, for starting an atrial-ventricular delay period when the atrial sense amplifier detects an atrial depolarization signal, and for inhibiting stimulation of the left ventricle and the right ventricle when a depolarization signal from either the left or the right ventricle is detected during the atrial-ventricular delay period;
a stimulating circuit for providing stimulating pulses for application to the left ventricle and the right ventricle at the end of the atrial-ventricular delay period if a depolarization signal is not detected from the left ventricle or the right ventricle during the atrial-ventricular delay period for effecting a coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability of the heart suffering from heart failure;
a first electrode adapted to be disposed in or about the left ventricle, the first electrode capable of sensing depolarization signals originating from the left ventricle and capable of providing a stimulating pulse to the left ventricle in response to the stimulating circuit; and
a second electrode adapted to be disposed in or about the right ventricle, the second electrode capable of sensing depolarization signals originating from the right ventricle and capable of providing a stimulating pulse to the right ventricle in response to the stimulating circuit.
0. 229. A heart failure treatment device for improving the pumping ability of a heart suffering from heart failure comprising:
an atrial sense amplifier capable of detecting depolarization signals originating from an atrium;
a ventricular sense amplifier capable of detecting depolarization signals originating from a left ventricle or a right ventricle;
pacing control circuitry, connected to the atrial sense amplifier, capable of starting an atrial-ventricular delay period when the atrial sense amplifier detects an atrial depolarization signal;
a stimulating circuit capable of providing stimulating pulses for application to the left ventricle and the right ventricle at the end of the atrial-ventricular delay period if a depolarization signal is not detected from the left ventricle or the right ventricle during the atrial-ventricular delay period for effecting coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability to the heart suffering form heart failure;
a first electrode responsive to the stimulating circuit and adapted to be disposed in or about the left ventricle, the first electrode capable of sensing depolarization signals originating from the left ventricle and capable of providing stimulating pulses to the left ventricle when the ventricular sense amplifier receives a depolarization signal from the left ventricle or the right ventricle; and
a second electrode responsive to the stimulating circuit and adapted to be disposed in or about the right ventricle, the second electrode capable of sensing depolarization signals originating from the right ventricle and capable of providing stimulating pulses to the right ventricle when the sense amplifier receives a depolarization signal from the left ventricle or the right ventricle.
0. 266. A heart failure treatment device for improving the pumping ability of a heart suffering from heart failure comprising:
a atrial sense amplifier for detecting depolarization signals originating from an atrium;
pacing control circuitry, connected to the atrial sense amplifier, for starting an atrial-ventricular delay period when the atrial sense amplifier detects an atrial depolarization signal;
a ventricular sense amplifier for detecting depolarization signals originating from the left ventricle or the right ventricle;
a stimulating circuit for stimulating the left ventricle and the right ventricle when a depolarization signal from the left ventricle or the right ventricle is detected by the ventricular sense amplifier during the atrial-ventricular delay period for effecting a coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability of the heart suffering from heart failure; and for stimulating the left ventricle and the right ventricle at the end of the atrial-ventricular delay period if a depolarization signal is not detected from the left ventricle or the right ventricle during the atrial-ventricular delay period for effecting a coordinated contraction of ventricles contracting in an incoordinate manner to improve the pumping ability of the heart suffering from heart failure;
a first electrode adapted to be disposed in or about the left ventricle, the first electrode capable of sensing depolarization signals originating from the left ventricle and capable of providing a stimulating pulse to the left ventricle in response to the stimulating circuit; and
a second electrode adapted to be disposed in or about the right ventricle, the second electrode capable of sensing depolarization signals originating from the right ventricle and capable of providing a stimulating pulse to the right ventricle in response to the stimulating circuit.
0. 1. A method for improving the hemodynamic efficiency of a sick heart comprising the steps of:
(a) detecting respective cardiac signals originating in the left and right ventricles of the heart;
(b) analyzing said cardiac signals and the absence thereof in an electronic control circuit; and
(c) providing electrical pulses from a stimulating circuit controlled by said control circuit to one, the other or both ventricles as required for effecting substantially simultaneous contraction of both ventricles, said step of analyzing including providing a control signal from said control circuit to said stimulating circuit for producing an electrical stimulating pulse to one or both ventricles in response to the absence of a detected cardiac signal from one or both ventricles within a time interval which is a small fraction of the pulse width of a detected cardiac signal.
0. 2. The method of
0. 3. The method of
0. 4. The method of
0. 5. A method for effecting simultaneous contraction of both left and right ventricles of a heart for improving hemodynamic efficiency comprising the steps of:
separately sensing for the presence of cardiac depolarization signals from both left and right ventricles;
determining whether said cardiac depolarization signals are simultaneously present in both the left and right ventricles; and
stimulating at least one ventricle substantially simultaneously with the contraction of at least one other ventricle in the event that said cardiac depolarization signals are determined not to be simultaneously present in both ventricles.
0. 6. A method of effecting simultaneous contraction of both left and right ventricles of a heart for improving hemodynamic efficiency comprising the steps of:
sensing the cardiac signals of the atria and separately sensing the cardiac depolarization signals of both the left and right ventricles;
determining whether said cardiac depolarization signals are simultaneously present in both the left and right ventricles;
stimulating at least one ventricle simultaneously with the contraction of at least one other ventricle after a predetermined A-V period in the event that said cardiac depolarization signals are determined not to be simultaneously present in both ventricles.
0. 7. A method of increasing the cardiac output of a sick heart comprising the steps of:
(a) implanting a pacing lead having at least two sensing/pacing electrodes in the body such that one of said sensing/pacing electrodes is in or on the right ventricle and the other of said sensing/ pacing electrodes is in or on the left ventricle;
(b) sensing depolarization signals picked up by said sensing/pacing electrodes upon their occurrence;
(c) determining whether the depolarization signals sensed in step (b) fail to occur within a predetermined time interval of one another and, if so;
(d) applying an electrical stimulating pulse to the sensing/pacing electrode associated with the ventricle not producing a depolarization signal within said time interval at the conclusion of said time interval.
0. 8. The method as in
0. 9. A bi-ventricular pacemaker, comprising:
(a) sense means for sensing ventricular depolarization signals originating in or on the right and left ventricles;
(b) means coupled to said sense means for initiating a time delay of a predetermined length which is short compared to the period of a QRS complex upon detection of a ventricular depolarization signal in one of said right or left ventricles; and
(c) pulse generator means operative upon the termination of said time delay for producing a ventricular simulating pulse and applying same to the other of said right or left ventricles unless a ventricular depolarization signal occurs in said other of said right of left ventricle prior to the expiration of said time delay.
0. 10. The bi-ventricular pacemaker as in
0. 11. The bi-ventricular pacemaker as in
(a) first and second set-reset flip-flop connected to be set by an output from said sense amplifier means;
(b) presetable counter means for initially containing a digital value representative of said time delay;
(c) means for incrementing or decrementing said digital value in said presettable counter means at regular intervals until a predetermined count is reached;
(d) means responsive to the value in said counter means reaching said predetermined count for producing a control signal;
(e) logic means coupled to said first and second flip-flops and to said presettable counter means for receiving said control signals; and wherein
(f) said pulse generator means is enabled by said logic means.
0. 12. The bi-ventricular pacemaker as in
0. 13. An atrial-coupled, bi-ventricular pacemaker for implantation or external use comprising atrial and ventricular sensing means for detecting cardiac signals, said sensing means including first and second ventricular electrodes connected in series for sensing and stimulating the right and the left ventricles, respectively, and an atrial electrode adapted to be disposed in an atrial chamber for detecting cardiac signals of the atria, all of said electrodes being connected to separate ECG amplifier means for amplifying the sensed signals; a control circuit coupled to said ECG amplifier means for analyzing the cardiac signals picked up by said sensing means and providing a control signal; and a stimulating circuit means for producing an electrical stimulating pulse to the left ventricle in the absence of a detected cardiac signal from the left ventricle, and to the right ventricle in the absence of a detected cardiac signal from the right ventricle, and to both ventricles in the absence of detected cardiac signals from both ventricles to effect substantially simultaneous contraction of both ventricles after a predetermined A-V delay period.
0. 14. The pacemaker of
0. 16. The heart stimulating device of
an electrode adapted to be disposed in or about the right ventricle to sense ventricular depolarization signals originating from the right ventricle.
0. 17. The heart stimulating device of
0. 18. The heart stimulating device of
0. 19. The heart stimulating device of
an electrode adapted to be disposed in or about the left ventricle to sense ventricular depolarization signals originating from the left ventricle.
0. 20. The heart stimulating device of
0. 21. The heart stimulating device of
0. 22. The heart stimulating device of
0. 23. The heart stimulating device of
a timer to initiate a delay period after the sense amplifier receives a ventricular depolarization signal.
0. 24. The heart stimulating device of
0. 25. The heart stimulating device of
0. 26. The heart stimulating device of
0. 28. The heart stimulating device of
an electrode means adapted to be disposed in or about the right ventricle for sensing ventricular depolarization signals originating from the right ventricle.
0. 29. The heart stimulating device of
0. 30. The heart stimulating device of
0. 31. The heart stimulating device of
an electrode means adapted to be disposed in or about the left ventricle for sensing ventricular depolarization signals originating from the left ventricle.
0. 32. The heart stimulating device of
0. 33. The heart stimulating device of
0. 34. The heart stimulating device of
0. 35. The heart stimulating device of
means for initiating a delay period after the receiving means receives a ventricular depolarization signal.
0. 36. The heart stimulating device of
0. 37. The heart stimulating device of
0. 38. The heart stimulating device of
0. 40. The method of
receiving ventricular depolarization signals originating from the right ventricle.
0. 41. The method of
applying the stimulating pulse to the left ventricle.
0. 42. The method of
applying stimulating pulses to both the left ventricle and the right ventricle.
0. 43. The method of
sensing ventricular depolarization signals originating from the left ventricle.
0. 44. The method of
applying the stimulating pulse to the right ventricle.
0. 45. The method of
applying stimulating pulses to both the left ventricle and the right ventricle.
0. 46. The method of
generating the stimulating pulses immediately after receiving a ventricular depolarization signal.
0. 47. The method of
initiating a delay period after receiving a ventricular depolarization signal.
0. 48. The method of
generating the stimulating pulse after the delay period.
0. 49. The method of
receiving ventricular depolarization signals from both the right ventricle and the left ventricle.
0. 50. The heart stimulating device of
generating stimulating pulses for both the right ventricle and the left ventricle.
0. 52. The heart stimulating device of
0. 53. The heart stimulating device of
0. 54. The heart stimulating device of
0. 55. The heart stimulating device of
0. 56. The heart stimulating device of
0. 57. The heart stimulating device of
0. 58. The heart stimulating device of
0. 59. The heart stimulating device of
a timer to initiate a delay period after the electrode senses a ventricular depolarization signal.
0. 60. The heart stimulating device of
0. 61. The heart stimulating device of
0. 63. The heart stimulating device of
0. 64. The heart stimulating device of
0. 65. The heart stimulating device of
0. 66. The heart stimulating device of
0. 67. The heart stimulating device of
0. 68. The heart stimulating device of
0. 69. The heart stimulating device of
0. 70. The heart stimulating device of
means for initiating a delay period after the electrode senses a ventricular depolarization signal.
0. 71. The heart stimulating device of
0. 72. The heart stimulating device of
0. 74. The method of
sensing a cardiac depolarization signal from the right ventricle.
0. 75. The method of
issuing a stimulating pulse to the left ventricle in response to sensing a cardiac depolarization signal from the right ventricle.
0. 76. The method of
issuing stimulating pulses to both ventricles in response to sensing a cardiac depolarization signal from the right ventricle.
0. 77. The method of
sensing a cardiac depolarization signal from the left ventricle.
0. 78. The method of
issuing a stimulating pulse to the right ventricle in response to sensing a cardiac depolarization signal from the left ventricle.
0. 79. The method of
issuing stimulating pulses to both ventricles in response to sensing a cardiac depolarization signal from the left ventricle.
0. 80. The method of
issuing the stimulating pulse immediately after the sensing of the ventricular depolarization signal.
0. 81. The method of
initiating a delay period after the sensing of the ventricular depolarization signal.
0. 82. The method of
issuing the stimulating pulse after the delay period.
0. 83. The method of
receiving ventricular cardiac depolarization signals from both the left and the right ventricles.
0. 85. The heart stimulating device of
0. 86. The heart stimulating device of
0. 87. The heart stimulating device of
0. 88. The heart stimulating device of
a timer to initiate a delay period after the sensing of the ventricular depolarization signal.
0. 89. The heart stimulating device of
0. 91. The heart stimulating device of
0. 92. The heart stimulating device of
0. 93. The heart stimulating device of
0. 94. The heart stimulating device of
means to initiate a delay period after the sensing of the ventricular depolarization signal.
0. 95. The heart stimulating device of
0. 97. The method of
applying the stimulating pulse to the left ventricle.
0. 98. The method of
applying stimulating pulses to both the left ventricle and the right ventricle.
0. 99. The method of
applying the stimulating pulse immediately upon the sensing of the ventricular depolarization signal.
0. 100. The method of
initiating a delay period after the sensing of the ventricular depolarization signal.
0. 101. The method of
applying the stimulating pulse after the delay period.
0. 103. The heart stimulating device of
0. 104. The heart stimulating device of
0. 105. The heart stimulating device of
0. 106. The heart stimulating device of
a timer to initiate a delay period after the sensing of the ventricular depolarization signal.
0. 107. The heart stimulating device of
0. 109. The heart stimulating device of
0. 110. The heart stimulating device of
0. 111. The heart stimulating device of
0. 112. The heart stimulating device of
means for initiating a delay period after the sensing of the ventricular depolarization signal.
0. 113. The heart stimulating device of
0. 115. The method of
applying the stimulating pulse to the right ventricle.
0. 116. The method of
applying a stimulating pulse to both the right ventricle and the left ventricle.
0. 117. The method of
applying the stimulating pulse immediately upon the sensing of the ventricular depolarization signal.
0. 118. The method of
initiating a delay period after the sensing of the ventricular depolarization signal.
0. 119. The method of
applying the stimulating pulse after the delay period.
0. 121. The heart stimulating device of
a control circuit, connected to the first and second electrodes, to determine whether ventricular cardiac depolarization signals are sensed by the second electrode within the predetermined atrial-ventricular delay period.
0. 122. The heart stimulating device of
0. 123. The heart stimulating device of
0. 125. The heart stimulating device of
a control means, connected to the atrial sensing means and the ventricular sensing means, for determining whether ventricular cardiac depolarization signals are sensed by the ventricular sensing means within the predetermined atrial-ventricular delay period.
0. 126. The heart stimulating device of
0. 127. The heart stimulating device of
0. 129. The method of
0. 130. The method of
0. 131. The method of
0. 134. The stimulating device of
0. 135. The stimulating device of
0. 137. The method of
0. 138. The method of
0. 139. The method of
0. 141. The method of
0. 142. The method of
0. 144. The heart stimulating device of
0. 145. The heart stimulating device of
0. 147. The method of
applying stimulating pulses to both the left ventricle and the right ventricle in response to the receiving of a ventricular depolarization signal in the right ventricle.
0. 148. The method of
locating an electrode through the coronary sinus and in the left ventricle.
0. 150. The heart stimulating device of
0. 151. The heart stimulating device of
0. 153. The method of
applying stimulating pulses to both the left ventricle and the right ventricle in response to the receiving of a ventricular depolarization signal in the left ventricle.
0. 154. The method of
locating an electrode through the coronary sinus and in the left ventricle.
0. 156. The method of
0. 157. The method of
0. 159. The heart stimulating device of
0. 160. The heart stimulating device of
0. 162. The method of
0. 163. The method of
0. 164. The method of
0. 165. The method of
0. 166. The method of
0. 167. The method of
0. 168. The method of
0. 169. The method of
0. 170. The method of
0. 172. The method of
0. 173. The method of
0. 174. The method of
0. 175. The method of
0. 176. The method of
0. 177. The method of
0. 178. The method of
0. 179. The method of
0. 180. The method of
0. 181. The method of
0. 182. The method of
0. 184. The heart failure treatment device of
0. 185. The heart failure treatment device of
0. 186. The heart failure treatment device of
0. 187. The heart failure treatment device of
0. 188. The heart failure treatment device of
0. 189. The heart failure treatment device of
0. 190. The heart failure treatment device of
0. 191. The heart failure treatment device of
0. 193. The heart failure treatment device of
0. 194. The heart failure treatment device of
0. 195. The heart failure treatment device of
0. 196. The heart failure treatment device of
0. 197. The heart failure treatment device of
0. 198. The heart failure treatment device of
0. 199. The heart failure treatment device of
0. 201. The heart failure treatment device of
0. 202. The heart failure treatment device of
0. 203. The heart failure treatment device of
0. 204. The heart failure treatment device of
0. 205. The heart failure treatment device of
0. 206. The heart failure treatment device of
0. 207. The heart failure treatment device of
0. 208. The heart failure treatment device of
0. 209. The heart failure treatment device of
0. 211. The method of
0. 212. The method of
0. 213. The method of
0. 214. The method of
0. 215. The method of
0. 217. The method of
0. 218. The method of
0. 219. The method of
0. 220. The method of
0. 221. The method of
0. 222. The method of
0. 223. The method of
0. 225. The heart failure treatment device of
0. 226. The heart failure treatment device of
0. 227. The heart failure treatment device of
0. 228. The heart failure treatment device of
0. 230. The heart failure treatment device of
0. 231. The heart failure treatment device of
0. 233. The heart failure treatment device of
0. 234. The heart failure treatment device of
0. 235. The heart failure treatment device of
0. 236. The heart failure treatment device of
0. 237. The heart failure treatment device of
0. 239. The method of
0. 240. The method of
0. 241. The method of
0. 242. The method of
0. 243. The method of
0. 244. The method of
0. 245. The method of
0. 246. The method of
0. 248. The method of
0. 249. The method of
0. 250. The method of
0. 251. The method of
0. 252. The method of
0. 253. The method of
0. 254. The method of
0. 255. The method of
0. 256. The method of
0. 257. The method of
0. 259. The heart failure treatment device of
0. 260. The heart failure treatment device of
0. 261. The heart failure treatment device of
0. 262. The heart failure treatment device of
0. 263. The heart failure treatment device of
0. 264. The heart failure treatment device of
0. 265. The heart failure treatment device of
0. 267. The heart failure treatment device of
0. 268. The heart failure treatment device of
0. 269. The heart failure treatment device of
0. 270. The heart failure treatment device of
0. 271. The heart failure treatment device of
0. 273. The heart failure treatment device of
0. 274. The heart failure treatment device of
0. 275. The heart failure treatment device of
0. 276. The heart failure treatment device of
0. 277. The heart failure treatment device of
0. 278. The heart failure treatment device of
0. 279. The heart failure treatment device of
0. 280. The heart failure treatment device of
0. 282. The method of
0. 283. The method of
0. 284. The method of
0. 285. The method of
0. 286. The method of
0. 288. The method of
0. 289. The method of
0. 290. The method of
0. 291. The method of
0. 292. The method of
0. 294. The heart failure treatment device of
0. 295. The heart failure treatment device of
0. 296. The heart failure treatment device of
0. 297. The heart failure treatment device of
0. 299. The heart failure treatment device of
0. 300. The heart failure treatment device of
0. 301. The heart failure treatment device of
0. 303. The heart failure treatment device of
0. 304. The heart failure treatment device of
0. 305. The heart failure treatment device of
0. 306. The heart failure treatment device of
0. 307. The heart failure treatment device of
0. 309. The method of
0. 311. The method of 310, further comprising locating an electrode through the coronary sinus to the left ventricle.
0. 312. The method of
0. 313. The method of
0. 317. The method of
0. 318. The method of
0. 319. The method of
0. 320. The method of
0. 321. The method of
0. 322. The method of
0. 323. The method of
0. 325. The method of
0. 326. The method of
0. 327. The method of
0. 328. The method of
0. 329. The method of
0. 330. The method of
0. 331. The method of
|
This is a continuation of Reissue application No. 08/547,691, filed Oct. 19, 1995 now U.S. Pat. No. RE 38,119 E, which is a continuation of Reissue application No. 07/890,280, filed May 29, 1992 now abandoned, which is a reissue of U.S. Pat. No. 4,928,688, all of which are incorporated herein by reference.
I. Field of the Invention
This invention pertains to medical devices, but more specifically, to a method for increasing the cardiac output of a patient suffering from congestive heart failure by stimulating the heart of the patient at multiple sites simultaneously.
II. Discussion of the Prior Art
Normally, impulses from the SA node affect contraction of the atria and then propagate to the AV node. The AV node, in turn, emits a second nerve impulse which affects contraction of the ventricles. These nerve impulses affect contraction, i.e., depolarization of the tissue of the heart, in a coordinated manner to circulate blood through the body. Cardiac pacers of the type herein described generally are useful for maintaining proper functional operation of a sick heart. Of many cardiac deficiencies which have in the past been diagnosed and treated, conduction difficulties have presented significant problems for which a pacer has been used for treatment. A particular conduction deficiency, known as AV branch block, inhibits the transfer of nerve impulses from the sinoatrial (SA) node to atrial-ventricular (AV) node. When a bundle block occurs, these nerve impulses are not properly transmitted from the SA node to the AV node and ventricles.
When this condition occurs, normal treatment is to employ a pacer which locks onto the rhythmic cycle of a atrial beating signal and supplies to the ventricles a stimulating impulse at a certain time thereafter to effect contraction of the ventricles. The time period between the occurrence of the atrial beat and the normal contraction of the ventricles is known as the A-V delay period. Generally, hemodynamic efficiency is somewhat dependent to the A-V delay period, thus the pacer must emit a stimulating pulse at a time to preserve an optimum A-V delay period.
Other forms of conduction deficiency, such as myocardial scarring and bundle branch block, cause slow conduction of nerve impulses, in which case, nerve impulses are indeed passed from the SA to the AV node, but in a time period which is slower than normal. The Q-R-S complex in this case would manifest itself in being very wide and hemodynamic efficiency also becomes lower than normal.
In each of the above-mentioned cardiac deficiencies, the heart does not contract in coordinated fashion. This uncoordinated movement increases depolarization time and results in more inefficient pumping rather than a more coordinated and simultaneous ventricular depolarization. In essence, such conduction deficiencies result in asynchrony between the left and right ventricle.
Additionally, arrhythmias of the heart produce uncoordinated ventricular contraction that affects the hemodynamic efficiency of the heart. Specifically, the recent paper “Incomplete Filling and Incoordinate Contraction as Mechanisms of Hypotension During Ventricular Tachycardia in Man”, published in Circulation, Vol. 68, No. 5, in 1983, describes that left ventricular function is severely disturbed by the disorganization of wall motion in hearts undergoing ventricular tachycardias. Moreover, it was found that hearts with impaired functions show profound reductions in pumping ability due to incoordinate contraction of the ventricles. It appears reasonable to believe, therefore, that any abnormal functioning heart that requires pacemaking or which has QRS widening will have a better hemodynamic efficiency if both ventricles are paced to contract in coordination with each other. There have been systems developed in the past employing a plurality of electrodes attached to the heart for effecting stimulation of a plurality of regions of the heart. For example, the Funke U.S. Pat. No. 3,937,226 discloses a cardiac electrical stimulation defibrillation system including a plurality of electrode terminals connected in a spaced relation on the heart. The electrodes, which provide stimulating and sensing, are each connected to amplifiers. The amplifiers are connected to electronic control circuit means configured to cause stimulation of all of the electrode terminals simultaneously in response to a sensed depolrization signal on the heart by at least one electrode terminal. In addition, the electronic control circuit is provided with a multivibrator means to synchronize the stimulation signal with the Q-R-S complex. Although Funke does teach the concept of simultaneous stimulation of a plurality of spaced electrodes, he does not disclose its specific use as a method of improving the cardiac output of patients suffering from congestive heart failure, nor does he discuss the specfic placement of the electrodes about the heart.
The Rockland et al U.S. Pat. No. 4,088,140 discloses a similar system to Funke's although a specific use as a pacemaker is stated in the patent. Rockland, et al discloses a demand anti-arrythmia pacemaker including a plurality of sensing electrodes connected to the heart to sense ventricular depolarizations. Electronic circuitry is provided having two paths of operation. A first path provides stimulation to one area of the heart if depolarization of a naturally occurring heart beat fails to occur within a first predetermined time period. In this first path, it is stated that the circuitry acts as a pacemaker in the event of skipped natural heartbeats. A second path provides stimulation to a plurality of locations on the heart if a depolarization signal is sensed on the heart within a second predetermined time period. In this second path, it is stated that the circuitry acts as a synchronous multiple electrode pacemaker or a synchronous multiple electrode defibrillator. Although, one example of an electrode placed in the intraventricular section and others in a spaced relation on the heart ventricles is given, there are no teachings of the specific placement of the electrodes on the heart nor the improvement of cardiac output from a sick heart. In addition, the electrodes perform either stimulating or sensing, not both, therefore a large number of electrodes is required in this system.
The Tacker, Jr. et al and McCorkle U.S. Pat. Nos. 4,548,203, 4,458,677 and 4,332,259, respectively, disclose the specific placement of an electrode in or around both left and right ventricles of the heart. The Tacker, Jr. et al patent discloses the placement of a catheter having one electrode in the right ventricle and another outside the heart and a third electrode placed on the left ventricle. The catheter electrodes, each being paired with the left ventricular electrode, are pulsed in sequence with a predetermined time separation resulting in uniform current density delivered to the heart. However, this pulsing scheme and configuration is disclosed for use in a ventricular defibrillation device and not for cardiac pacing to improve cardiac output wherein a more precise synchronization of stimulation signals with the Q-R-S complex is required.
The McCorkle, Jr. patents disclose the specific placement of an electrode in the right ventricle and another electrode in the coronary sinus surrounding the left ventricle for connection to a pacemaker. However, there is no specific technique disclose of providing stimulating signals to the electrodes to perform a pacemaking function.
In light of the above difficulties and shortcomings of the prior art, an objective of the present invention is to provide a cardiac pacer for increasing hemodynamic efficiency of a heart experiencing a conduction deficiency.
Another objective of the invention is to ensure a more coordinated and simultaneous ventricular depolarization of both left and right ventricles of the heart.
A yet further objective of this invention is to provide a cardiac pacer suitable for being implanted in a manner so as to impose a minimal surgical risk during implantation thereof.
A further objective of this invention is to provide a method and apparatus of separately sensing and stimulating each ventricle of the heart in order for effecting simultaneous contraction automatically of both ventricles of the heart to narrow the QRS complex of a failing heart and thereby cause an increase in blood pressure and cardiac output.
The method of the present invention involves a procedure for pacing of the heart in a particular way so as to improve its contraction pattern, and thereby augment the movement of blood through the heart. Patients suffering from severe congestive heart failure, which is found not to respond well to conventional drug therapy and to have a conduction defect in the ventricle resulting in a widen Q-R-S complex have been aided by a pacing regimen in which stimulating pulses are simultaneously applied to both ventricles by way of a demand pacemaker or asynchronous pacemaker.
It is theorized that a considerable part of the hemodynamic impairment in refractory congestive heart failure with conduction defects is due to an incoordinate contraction of the heart, so that a part of the heart muscle contracts and balloons out the part that is not contracting. When the latter area of the heart muscle does finally contract, the former has relaxed, so that a large part of the blood volume is merely shunted back and forth within the heart rather than being ejected as would happen with a more coordinate contraction pattern.
To attain the foregoing and other objectives, the present invention comprises, a bi-ventricular cardiac pacer having detecting and stimulating circuits for effecting substatially simultaneous contraction of both left and right ventricles of the heart. In the preferred embodiment, the bi-ventricular pacer comprises ECG amplifier means for separately processing sensed cardiac signals from each of the right and left ventricles. The amplified sensed signals are used to determined where possible abnormal conduction delays exist on the heart and to activate an electrical stimulator for stimulating the appropriate abnormally functioning part of the heart. More specifically, the stimulator responds to the control circuit to issue stimulating pulses simultaneously to either the left or right ventricle, as appropriate. The stimulator may be of the demand type wherein pacing pulses are only issued in the absence of a normal Q-R-S complex for one or the other of the two ventricles (e.g., occasional bundle branch block or slow conduction), or the nondemand type wherein pacing pulses are always issued (e.g., permanent bundle branch block or slow conduction).
To convey and sense signals to and from the heart, the present invention includes a pacing lead assembly comprising first and second separate electrodes. The first electrode is preferably introduced through the superior vena cava into the right ventricle and the second electrode is introduced through the coronary sinus to the left ventricle. Both lead segments include a sensing and pacing tip electrode which serves to both sense a cardiac depolarization signal or to apply a stimulating pulse from an implanted pulse generator to the ventricle.
Additionally, to preserve a predetermined A-V delay period, additional atrial sensing electrodes may be placed on or around the atrial chambers of the heart and connected to the control circuit. The control circuit responds to the sensed atrial and ventricular depolarization signals to provide simultaneous ventricular contraction signals applied to the left and right ventricles following a preset A-V delay period.
The advantages of the present invention include a more precise and coordinated simultaneous ventricular depolarization of both the right and left ventricular to thereby increase hemodynamic efficiency of a patient experiencing congestive heart failure or weak contractions.
These together with other objects and advantages which will become subsequently apparent reside in the details of construction and operation as more fully hereinafter described and claimed, reference being had to the accompanying drawings forming a part hereof, wherein like numerals refer to like parts throughout.
In operation, the electrodes 13 and 15 are disposed in or about the right and left ventricles, respectively. A preferred surgical procedure for-implanting the lead 12 is to extend it through the superior vena cava 28 so that the sensing stimulating tip 13 thereof lodges in the internal chamber of the right ventricle of the heart 10. A preferred surgical-procedure for implanting lead branch 14 is to extend it through the coronary sinus (not shown) of the heart 10 so that the sensing/stimulating tip 15 thereof lodges directly in or about the coronary sinus and left ventricle. Although it is described that electrodes 13 and 15 perform both sensing and pacing, it is possible for testing and examination, that separate unipolar or bipolar sensing and stimulating electrodes may be used.
When attached to the heart, the electrodes 13 and 15 sense cardiac signals in the form of well-known Q-R-S complex at separate sites within the left and right ventricles. The ECG amplifiers 16 and 17 feed the amplified versions of these signals to the control circuit 20.
The control circuit 20 analyzes the cardiac signals to determine whether an abnormal conduction exists. Specifically, if a cardiac signal is received from the left ventricle but not from the right ventricle, the control circuit 20 provides a control signal to the stimulator 22 to issue a stimulating pacing pulse over conductors 24 and 18 and lead branch 12 to the right ventricle, via the sensing/stimulating tip electrodes 13. Similarly, the control circuit 20 provides a control signal to the stimulator 22 to issue a stimulating pacing pulse over lead branch 14 to the left ventricle, via sensing/stimulating tip electrode 15, if a cardiac depolarization signal is received from the right ventricle, but not from the left ventricle. It is also possible to sense a depolarization signal from only one ventricular chamber and then unconditionally stimulate both ventricular chambers. This is wasteful of power which is a concern only if the stimulator is totally implanted and must rely on an implanted battery power source.
The timing of the stimulating pacing pulse from the stimulator 22 is such that both ventricles will contract substantially simultaneously. Where both ventricles are unconditionally stimulated upon the occurrence of a QRS complex on only one side, the fact that ventricular site which had produced a Q-R-S complex is immediately stimulated along with the other ventricle does not cause a problem since the site producing that complex is still refractory at the time it is stimulated.
It is also possible that no cardiac signals are sensed from either ventricle, possibly resulting from complete conduction failure between the sinoatrial node and the atrialventricular node. In this case, the control circuit 20 will again activate the stimulator 22 to provide stimulating signals to both ventricles simultaneously.
In an alternative embodiment of the invention, the issuance of pacing pulses to the ventricles is time-coupled to the rhythmic cycle of the atrial beat of the heart to preserve a preset atrial-ventricular delay period of about 120 to 200 milliseconds. Additional atrial sensing is accomplished, via lead 23 and a sense electrode 25 similar to the ventricular leads 12 and 14, but disposed in or about the right atrial chamber and connected to the control circuit 20, via atrial sense amplifier 27. The control circuit 20 may be configured to respond to the sensed atrial and ventricular signals to activate the stimulator for providing appropriate simultaneous stimulating signals to the ventricles as described above in accordance with the predetermined A-V delay period.
In the case where the conduction of the natural stimulating signal originating at the sinoatrial node of the heart 10 is only partially blocked or slowed, the ventricles may partially or incompletely contract, in which case hemodynamic efficiency is reduced. Under these circumstances, provision is made in the control circuit 20 for determining whether a Q-R-S cardiac signal, although present, is weak or slow, and if so, to activate the stimulator 22 to stimulate the ventricles of the heart by passing pacing pulses simultaneously thereto.
To accomplish bi-ventricular pacing, activity is sensed in both the left and the right ventricle. When a ventricular contraction is sensed in either ventricle, a timer is initiated. If within a time window established by said timer, the contraction is sensed in the other ventricle, all pacing is inhibited because the natural contractions are deemed to be simultaneous. On the other hand, if ventricular contractions are not sensed in both ventricles within a period of coincidence defined by the time delay, at the end of this delay, the pacing pulse will be emitted, but only to the ventricle for which a QRS complex has not been sensed. Generally, ventricular contractions which occur within 5-10 milliseconds of each other result in sufficient hemodynamic efficiency so as to not require treatment. Hence, the delay window may be of this order of magnitude. As used herein, the term “substantially simultaneous contraction” includes the occurrence of natural contractions of both ventricles within the window period or an evoked contraction of one or both ventricles immediately following the expiration of the window period.
Operation of the circuit of
Let if first be assumed that a left ventricle contraction procedes that of the right. In this case, an R-wave signal propagates through amplifier 16 to set the Set-Reset type flip-flop 30. a logical “1” signal passes through OR gate 32 to clock D-type of flop 34 to the “set” state which, in turn, initiates the aforementioned delay timing. Window register 36 is loaded with a digital count value which is representative of the desired delay window, e.g., 5-10 ms. This may be either a fixed, hard-wired register or, alternatively, a programmable register which may be set by telemetry means in a known manner. When the preset enable input (PE) in high, counter 38 is held at a digital count corresponding to the value held in window register 36. When flip-flop 34 is set, the PE on counter 38 is removed, allowing the counter to be decremented with each clock pulse provided on clock line 40. At the end of the preprogrammed window delay interval, counter 38 is decremented to zero, causing the zero detect (ZD) line 42 to go high. The leading edge of the zero detect pulse is used to trigger a ventricle pacing pulse from pulse generator 44, via gates 54 and 56, as required. The pulse generator circuitry 44 converts this leading edge trigger to a pulse of the proper amplitube and duration for effective stimulation of the right ventricle. Note that, since under the assumed conditions flip-flop 30 has been set, AND gate 48 is disabled and, therefore, pulse generator 50 is inhibited from generating a left ventricle pacing pulse.
Next to be considered is the case where a right ventricle contraction has not been sensed within the prescribed window interval. In this case, flip-flop 52 remains reset and AND gate 54 is enabled which allows the zero detect pulse ZD to propagate through OR gate 56 to trigger pulse generator 44, thus stimulating the right ventricle. If, however, a right ventricle contraction has been detected, flip-flop 52 would have been set prior to the generation of the ZD pulse and, in this case, both AND gates 48 and 54 are disabled and no pacing pulse in either ventricle is generated.
It can be seen from the symmetry of the circuit that the operation is identical if the right ventricle contraction precedes the left ventricle contraction by more than the preprogrammed delay interval. In either case, the setting of either flip-flop 30 or 52 causes 52 causes the initiation of the timing window delay interval. When one of these flip-flop sets, the other must set within the window period, otherwise a pacing pulse will be generated in the unsensed ventricle.
The bi-ventriclar pacing control circuitry may be combined with other well-known pacer control circuitry such that the bi-ventriclar mode can be realized in combination with any other pacing mode, such as VVI, DDD, VOO. Line 58 is the logical OR of either of left ventricle event or a right ventricle event. It may be connected to other pacing control circuitry 62 in place of the signal which is normally responsive to only activity in the left ventricle. A sensed ventricle event thus inhibits the generation of a pacing trigger from another pacing circuitry and leaves the control of pacing in the alternate ventricle, as required, to the circuitry of FIG. 1. If line 58 is not activated within the escape interval of the other pacing control circuitry, a paced ventricle trigger signal on line 60 is produced which propagates through both OR gate 62 and OR gate 56 to trigger pacing pulses in both ventricles.
It is also contemplated that when a ventricular depolarization signal is sensed in one or the other of the ventricles, that a stimulating pulse may also be immediately delivered, on an unconditional basis, to both ventricles, via the implanted leads 13 and 15, thus resulting in a coordinated contraction of both ventricles.
The foregoing illustrate preferred arrangements for carrying out the objectives of this invention. Modifications and variations can obviously be made by those skilled in the art without departing from the true spirit and scope of the invention. For instance, the circuit may be employed to simultaneously pace the auricles, instead of ventricles, if such is required to improve pumping efficiency. The arrangement may also be employed as an improvement of conventional pacers thereby to improve their performance. As stated herein, the inventive arrangement can be used in an implanted device or in an external treating, diagnostic or testing device. Accordingly, the invention is limited only by the scope of the appended claims rather than by what is shown and described. Therefore, it is the intent to cover all such modifications and alternate embodiments as may come within the true scope of this invention.
Patent | Priority | Assignee | Title |
10092186, | Dec 18 2002 | Cardiac Pacemakers, Inc. | Advanced patient management with environmental data |
10413196, | Dec 18 2002 | Cardiac Pacemakers, Inc. | Device for reporting heart failure status |
10905884, | Jul 20 2012 | MAXWELL BIOMEDICAL, INC , | Multi-stage atrial cardioversion therapy leads |
7751884, | Apr 28 2005 | Cardiac Pacemakers, Inc. | Flexible neural stimulation engine |
7764999, | Jan 28 2005 | Cardiac Pacemakers, Inc | Linear electrode array to treat mitral regurgitation |
7769447, | Apr 28 2005 | Cardiac Pacemakers, Inc. | Cardiac pacemaker with table-based pacing mode implementation |
7805199, | Mar 06 2002 | Cardiac Pacemakers, Inc. | Method and apparatus for establishing context among events and optimizing implanted medical device performance |
7953480, | Jan 28 2005 | Cadiac Pacemakers, Inc. | Atrial pacing therapy for treating mitral regurgitation |
7983745, | Dec 18 2002 | Cardiac Pacemakers, Inc. | Advanced patient management with environmental data |
7983759, | Dec 18 2002 | Cardiac Pacemakers, Inc | Advanced patient management for reporting multiple health-related parameters |
8043213, | Dec 18 2002 | Cardiac Pacemakers, Inc | Advanced patient management for triaging health-related data using color codes |
8160716, | Mar 06 2002 | Cardiac Pacemakers, Inc. | Method and apparatus for establishing context among events and optimizing implanted medical device performance |
8352029, | Apr 28 2005 | Cardiac Pacemakers, Inc. | Flexible neural stimulation engine |
8483825, | Dec 20 2007 | Cardiac Pacemakers, Inc | AV delay features |
8694116, | Mar 06 2002 | Cardiac Pacemakers, Inc. | Method and apparatus for establishing context among events and optimizing implanted medical device performance |
8942800, | Apr 20 2012 | ZOLL Medical Corporation | Corrective prompting system for appropriate chest compressions |
8942829, | Jan 20 2011 | Medtronic, Inc.; Medtronic, Inc | Trans-septal lead anchoring |
9108061, | Jan 28 2005 | Cardiac Pacemakers, Inc. | Linear electrode array to treat mitral regurgitation |
9375566, | Dec 18 2002 | Cardiac Pacemakers, Inc. | Device for reporting heart failure status |
9480848, | Dec 18 2002 | Cardiac Pacemakers, Inc. | Advanced patient management with environmental data |
Patent | Priority | Assignee | Title |
3345990, | |||
3431912, | |||
3433228, | |||
3595242, | |||
3648707, | |||
3747604, | |||
3814106, | |||
3903897, | |||
3937226, | Jul 10 1974 | Medtronic, Inc. | Arrhythmia prevention apparatus |
4052991, | Mar 19 1971 | Method of stimulating the heart | |
4057067, | Apr 06 1976 | Atrioventricular electrode | |
4088140, | Jun 18 1976 | Medtronic, Inc. | Demand anti-arrhythmia pacemaker |
4303075, | Feb 11 1980 | MIROWSKI FAMILY VENTURES L L C | Method and apparatus for maximizing stroke volume through atrioventricular pacing using implanted cardioverter/pacer |
4312355, | Jan 11 1978 | MEDTRONIC, INC , A MN CORP | Heart pacemaker |
4332259, | Sep 19 1979 | Intravenous channel cardiac electrode and lead assembly and method | |
4335727, | May 30 1980 | Pacemaker assembly having ventricular inhibited and ventricular triggered pacemaker units | |
4354497, | May 23 1977 | Medtronic, Inc. | Cardiac depolarization detection apparatus |
4378020, | Aug 20 1981 | Pacesetter, Inc | Dual chamber pacer |
4386610, | May 27 1980 | Pacesetter, Inc | Ventricular-inhibited cardiac pacer |
4401119, | Feb 17 1981 | Medtronic, Inc. | Prolongation of timing intervals in response to ectopic heart beats in atrial and ventricular pacemakers |
4418695, | Mar 14 1978 | Implantable cardiac stimulator having therapeutic diagnostic functions | |
4429697, | Apr 12 1982 | Pacesetter, Inc | Dual chamber heart pacer with improved ventricular rate control |
4452248, | Oct 13 1981 | PACESTTER SYSTEMS, INC , A A CORP OF CA | Bidirectional pacemaker |
4458677, | Sep 19 1979 | Intravenous channel cardiac electrode and lead assembly and method | |
4541417, | Jun 07 1982 | Coronary augmenter | |
4548203, | Jun 01 1982 | MEDTRONIC, INC A CORP OF MINNESOTA | Sequential-pulse, multiple pathway defibrillation method |
4554922, | Sep 30 1982 | Method of inhibiting cardiac arrhythmias | |
4559946, | Jun 18 1982 | MIROWSKI FAMILY VENTURES L L C | Method and apparatus for correcting abnormal cardiac activity by low energy shocks |
4624260, | May 07 1985 | INTERMEDICS, INC | Pacemaker with conditional atrial tracking capability |
4685446, | Feb 21 1984 | Method for using a ventricular assist device | |
4705043, | Jul 05 1985 | MIROWSKI FAMILY VENTURES L L C | Electrophysiology study system using implantable cardioverter/pacer |
4727877, | Dec 18 1984 | Medtronic, Inc. | Method and apparatus for low energy endocardial defibrillation |
4774950, | Oct 06 1987 | Medtronic, Inc | Hemodynamically responsive system for and method of treating a malfunctioning heart |
4790317, | Oct 25 1985 | Apparatus for recognition and termination of ventricular tachycardia and ventricular fibrillation | |
4799486, | Mar 13 1987 | Cardiac Pacemakers, Inc. | Refractoriless atrial sensing in dual chamber pacemakers |
4817608, | May 29 1987 | MIROWSKI FAMILY VENTURES L L C | Cardioverting transvenous catheter/patch electrode system and method for its use |
4827932, | Feb 27 1987 | INTERMEDICS, INC , A TX CORP | Implantable defibrillation electrodes |
4827934, | Oct 27 1987 | Pacesetter, Inc | Sensing margin detectors for implantable electromedical devices |
4830006, | Jun 17 1986 | INTERMEDICS, INC | Implantable cardiac stimulator for detection and treatment of ventricular arrhythmias |
4925443, | Feb 27 1987 | VASCOR, INC A CORP OF PENNSYLVANIA | Biocompatible ventricular assist and arrhythmia control device |
4932407, | Dec 15 1988 | Medtronic, Inc. | Endocardial defibrillation electrode system |
4958632, | Jul 20 1978 | Medtronic, Inc | Adaptable, digital computer controlled cardiac pacemaker |
4967749, | Oct 06 1987 | Medtronic, Inc | Hemodynamically responsive system for and method of treating a malfunctioning heart |
4974588, | Jun 20 1985 | Medtronic, Inc. | Cardioversion and defibrillation lead system |
5014696, | Jan 14 1987 | Medtronic, Inc. | Endocardial defibrillation electrode system |
5024222, | Feb 21 1990 | Pacesetter, Inc | Hemodynamically rate responsive pacemaker and method of automatically adjusting the escape and A-V intervals |
5083563, | Feb 16 1990 | Pacesetter, Inc | Implantable automatic and haemodynamically responsive cardioverting/defibrillating pacemaker |
5099838, | Dec 15 1988 | Medtronic, Inc. | Endocardial defibrillation electrode system |
5111811, | Jun 20 1985 | Medtronic, Inc. | Cardioversion and defibrillation lead system with electrode extension into the coronary sinus and great vein |
5129394, | Jan 07 1991 | Medtronic, Inc. | Method and apparatus for controlling heart rate in proportion to left ventricular pressure |
5158097, | Jun 08 1990 | Allegheny-Singer Research Institute | Paraneural stimulating lead |
5213098, | Jul 26 1991 | Medtronic, Inc. | Post-extrasystolic potentiation stimulation with physiologic sensor feedback |
5251621, | Dec 18 1991 | Pacesetter, Inc | Arrhythmia control pacer using skeletal muscle cardiac graft stimulation |
5334222, | Nov 03 1992 | Cardiac Pacemakers, Inc. | Cardiac stimulating apparatus and method for heart failure therapy |
5545204, | Mar 08 1993 | Sequential cardiostimulation system (DDD) using a single electrocatheter inserted through the coronary sinus | |
5584868, | Nov 03 1992 | Cardiac Pacemakers, Inc. | Cardiac stimulating apparatus and method for heart failure therapy |
5626620, | Feb 21 1995 | Medtronic, Inc. | Dual chamber pacing system and method with continual adjustment of the AV escape interval so as to maintain optimized ventricular pacing for treating cardiomyopathy |
5755766, | Jan 24 1997 | Cardiac Pacemakers, Inc | Open-ended intravenous cardiac lead |
5899930, | Sep 29 1997 | Cardiac Pacemakers, Inc. | Triple port and quadruple port in-line header designs |
5902324, | Apr 28 1998 | Medtronic, Inc.; Medtronic, Inc | Bi-atrial and/or bi-ventricular sequential cardiac pacing systems |
5919209, | May 13 1996 | Medtronic, Inc | System and method for myocardial revalidation and therapy by high rate pacing |
5935160, | Jan 24 1997 | Cardiac Pacemakers, Inc | Left ventricular access lead for heart failure pacing |
6185459, | Aug 17 1998 | Medtronic, Inc | Method and apparatus for prevention of atrial tachyarrhythmias |
DE1401247, | |||
DE2119255, | |||
EP17447, | |||
EP39269, | |||
WO8203783, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Aug 08 2002 | Mirowski Family Ventures, L.L.C. | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Date | Maintenance Schedule |
Oct 23 2010 | 4 years fee payment window open |
Apr 23 2011 | 6 months grace period start (w surcharge) |
Oct 23 2011 | patent expiry (for year 4) |
Oct 23 2013 | 2 years to revive unintentionally abandoned end. (for year 4) |
Oct 23 2014 | 8 years fee payment window open |
Apr 23 2015 | 6 months grace period start (w surcharge) |
Oct 23 2015 | patent expiry (for year 8) |
Oct 23 2017 | 2 years to revive unintentionally abandoned end. (for year 8) |
Oct 23 2018 | 12 years fee payment window open |
Apr 23 2019 | 6 months grace period start (w surcharge) |
Oct 23 2019 | patent expiry (for year 12) |
Oct 23 2021 | 2 years to revive unintentionally abandoned end. (for year 12) |